Non-invasive brain stimulation (NIBS), including transcranial magnetic stimulation (TMS),
and transcranial direct current stimulation (tDCS), is a potentially effective treatment strategy …

Drug consumption is driven by a drug's pharmacological effects, which are experienced as
rewarding, and is influenced by genetic, developmental, and psychosocial factors that …

Aberrant patterns of brain functional connectivity in the default mode network (DMN) have
been observed across different classes of substance use disorder (SUD) and are associated …

There is growing interest in non-invasive brain stimulation (NIBS) as a novel treatment
option for substance-use disorders (SUDs). Recent momentum stems from a foundation of …

Background Methamphetamine (METH) use is on the rise globally, with the number of
treatment seekers increasing exponentially across the globe. Evidence-based therapies are …

Background Brain stimulation interventions are increasingly used to reduce craving and
consumption in individuals with drug addiction or excessive eating behavior. However, the …

The neurobiological mechanisms underlying prefrontal transcranial direct current stimulation
(tDCS) remain elusive. Randomized, sham-controlled trials in humans and rodents applying …

While pharmacological, behavioral and psychosocial treatments are available for substance
use disorders (SUDs), they are not always effective or well-tolerated. Neuromodulation (NM) …

Understanding and reducing variability of response to transcranial direct current stimulation
(tDCS) requires measuring what factors predetermine sensitivity to tDCS and tracking …

Substance use disorders (SUDs) are a growing public health concern with only a limited
number of approved treatments. However, even approved treatments are subject to limited …